Venous thrombembolism, thrombophilic defects, combined oral contraception and anticoagulation
- 126 Downloads
Several genetic polymorphisms increase the risk for venous thrombembolism (VTE). In particular, combined oral contraceptives (COCs) are known to enhance the risk for VTE and are therefore contraindicated.
We present here the case of a patient with protein S deficiency, who has used COCs together with anticoagulatory therapy (Phenprocoumon) after suffering from deep venous thromboses for 4 years. At the time of her first consultation at our clinic, the ultrasound examination showed a complete involution of her venous thrombosis.
COCs can be used in patients with thrombogenic mutations and anticoagulatory therapy in individual cases.
KeywordsThrombembolism Anticoagulation Contraception Protein S deficiency Oral contraceptives
Conflict of interest statement
- 9.Aiach M, Alhenc-Gelas M, Borgel D et al (2006) Coagulation factor mutations and thrombosis. Med Sci (Paris) 22:985–989Google Scholar
- 11.Bucciarelli P, Rosendaal FR, Tripodi A et al (1999) Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol 19:1026–1033PubMedGoogle Scholar
- 14.De Stefano V, Leone G, Mastrangelo S et al (1994) Clinical manifestations and management of inherited thrombophilia. Retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 72:352–358PubMedGoogle Scholar
- 17.World Health Organization Collaborative Study of Cardiovascular Disease, Steroid Hormone Contraception (1998) Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. Contraception 57:315–324. doi: 10.1016/S0010-7824(98)00041-9 CrossRefGoogle Scholar
- 20.Palareti G, Leali N, Coccheri S et al (1996) Bleeding complications of oral anticoagulant treatment: an inceptioncohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 348:423–428. doi: 10.1016/S0140-6736(96)01109-9 PubMedCrossRefGoogle Scholar